Captopril Polyvinyl Alcohol/Sodium Alginate/Gelatin-Based Oral Dispersible Films (ODFs) with Modified Release and Advanced Oral Bioavailability for the Treatment of Pediatric Hypertension.

Abdelkader, Hamdy; Abdel-Aleem, Jelan A; Mousa, Heba Salah; Elgendy, Marwa O; Al Fatease, Adel; Abou-Taleb, Heba A

Abdelkader, Hamdy; Abdel-Aleem, Jelan A; Mousa, Heba Salah; Elgendy, Marwa O; Al Fatease, Adel; Abou-Taleb, Heba A.

Abdelkader H; Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.
Abdel-Aleem JA; Department of Industrial Pharmacy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt.
Mousa HS; Pharmaceutical Analytical Chemistry Department, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt.
Elgendy MO; Department of Clinical Pharmacy, Beni-Suef University Hospitals, Faculty of Medicine, Beni-Suef University, Beni Suef 62521, Egypt.
Al Fatease A; Department of Clinical Pharmacy, Faculty of Pharmacy, Nahda University (NUB), Beni Suef 62521, Egypt.
Abou-Taleb HA; Department of Pharmaceutics, College of Pharmacy, King Khalid University, Abha 62223, Saudi Arabia.

Pharmaceuticals (Basel) ; 16(9)2023 Sep 19.

Article en En | MEDLINE | ID: mdl-37765131